FDA Warning Letter — Xiamen Origin Biotech Co. Ltd.

Case 496704 — FEI 3010307355

The FDA took a Warning Letter action against Xiamen Origin Biotech Co. Ltd. on July 19, 2016 (Xiamen, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Xiamen Origin Biotech Co. Ltd.
Date
July 19, 2016
Fiscal Year
2016
Product Type
Drugs
Center
CDER
Location
Xiamen (China)